2 research outputs found

    Recurrence plot analysis of heart rate variability in end-stage renal disease treated twice-weekly by hemodialysis with or without intradialytic hypotension

    No full text
    Recurrence quantitative analysis (RQA) indices of heart rate variability (HRV) have shown a different adjustment in the sympathetic-driven dynamical response to active standing (AS) and hemodialysis (HD), characterized by increased laminar states in HRV. AS test is a maneuver in which subjects actively change their body posture from supine position (SP) to AS. In end-stage renal disease (ESRD) patients treated twice-weekly by HD, we found reduced changes in RQA indices to AS before HD that are partially recovered after treatment; laminarity, trapping time and recurrence time of the second type values were significantly lower in SP than during AS (p<0.05p<0.05). Patients who developed intradialytic hypotension (IDH) did not show a significant response to AS in contrast with patients who did not develop IDH. Also, the mean duration of heartbeat intervals significantly influenced RQA indices (p<0.05p<0.05), and this correlation depended on the observation moment (before or after HD). These findings suggest that the cardiac response to the autonomic modulation measured by RQA is different in IDH patients even before HD. Furthermore, the influence of the mean heart rate changes seems to play an important role in the short-term control of HRV behavior in ESRD

    Ibero–American Consensus on Low- and No-Calorie Sweeteners: Safety, Nutritional Aspects and Benefits in Food and Beverages

    Get PDF
    International scientific experts in food, nutrition, dietetics, endocrinology, physical activity, paediatrics, nursing, toxicology and public health met in Lisbon on 2&ndash;4 July 2017 to develop a Consensus on the use of low- and no-calorie sweeteners (LNCS) as substitutes for sugars and other caloric sweeteners. LNCS are food additives that are broadly used as sugar substitutes to sweeten foods and beverages with the addition of fewer or no calories. They are also used in medicines, health-care products, such as toothpaste, and food supplements. The goal of this Consensus was to provide a useful, evidence-based, point of reference to assist in efforts to reduce free sugars consumption in line with current international public health recommendations. Participating experts in the Lisbon Consensus analysed and evaluated the evidence in relation to the role of LNCS in food safety, their regulation and the nutritional and dietary aspects of their use in foods and beverages. The conclusions of this Consensus were: (1) LNCS are some of the most extensively evaluated dietary constituents, and their safety has been reviewed and confirmed by regulatory bodies globally including the World Health Organisation, the US Food and Drug Administration and the European Food Safety Authority; (2) Consumer education, which is based on the most robust scientific evidence and regulatory processes, on the use of products containing LNCS should be strengthened in a comprehensive and objective way; (3) The use of LNCS in weight reduction programmes that involve replacing caloric sweeteners with LNCS in the context of structured diet plans may favour sustainable weight reduction. Furthermore, their use in diabetes management programmes may contribute to a better glycaemic control in patients, albeit with modest results. LNCS also provide dental health benefits when used in place of free sugars; (4) It is proposed that foods and beverages with LNCS could be included in dietary guidelines as alternative options to products sweetened with free sugars; (5) Continued education of health professionals is required, since they are a key source of information on issues related to food and health for both the general population and patients. With this in mind, the publication of position statements and consensus documents in the academic literature are extremely desirable
    corecore